share_log

石四药集团(02005.HK):呋塞米注射液获批准通过仿制药质量和疗效一致性评价

SSY GROUP (02005.HK): Furosemide injection has been approved to pass the consistency evaluation of generic drug quality and efficacy.

Gelonghui Finance ·  Dec 26 15:55

On December 27, Gelonghui | Shijiyao Group (02005.HK) announced that the Group's furosemide injection (2ml: 20mg) has obtained approval from the China National Drug Administration to pass the consistent evaluation of the quality and efficacy of generic drugs. Furosemide injection is mainly used to treat various edematous diseases, hypertension, hyperkalemia and hypercalcemia, dilute hyponatremia, excessive antidiuretic hormone secretion (SIADH), acute drug poisoning (such as barbiturate poisoning), and prevent acute renal failure.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment